Clinical Trial for the Prevention of Vasovagal Syncope
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The main question in the study is whether people taking fludrocortisone are less likely to
faint than people taking an inactive pill called a placebo.
Fludrocortisone is a drug that stimulates the body to retain salt and water. The
investigators know from some studies that it might prevent people from fainting at home and
in the community, while they are carrying on with their lives. There is some evidence that
salt and water retention help prevent fainting, but no one has a clear idea about whether
this is true. This study will try to determine if that is true.